The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure

被引:111
作者
Cotter, G [1 ]
Moshkovitz, Y
Kaluski, E
Milo, O
Nobikov, Y
Schneeweiss, A
Krakover, R
Vered, Z
机构
[1] Assaf Harofeh Med Ctr, Dept Cardiol, IL-70300 Zerifin, Israel
[2] Ramat Marpe Hosp, Dept Cardiac Surg, Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Dept Biostat, IL-52621 Tel Hashomer, Israel
关键词
cardiac power; vascular resistance; acute congestive heart failure;
D O I
10.1016/S1388-9842(03)00100-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Conventional hemodynamic indexes (cardiac index (CI), and pulmonary capillary wedge pressure) are of limited value in the diagnosis and treatment of patients with acute congestive heart failure (CHF). Patients and methods: We measured CI, wedge pressure, right atrial pressure (RAP) and mean arterial blood pressure (MAP) in 89 consecutive patients admitted due to acute CHF (exacerbated systolic CHF, n = 56; hypertensive crisis, n = 5; pulmonary edema, n = 11; and cardiogenic shock, n = 17) and in two control groups. The two control groups were 11 patients with septic shock and 20 healthy volunteers. Systemic vascular resistance index (SVRi) was calculated as SVRi = (MAP-RAP)/CI. Cardiac contractility was estimated by the cardiac power index (Cpi), calculated as CI X MAP. Results and discussion: We found that CI < 2.7 l/min/m(2) and wedge pressure > 12 mmHg are found consistently in patients with acute CHF However, these measures often overlapped in patients with different acute CHF syndromes, while Cpi and SVRi permitted more accurate differentiation. Cpi was low in patients with exacerbated systolic CHF and extremely low in patients with cardiogenic shock, while SVRi was increased in patients with exacerbated systolic CHF and extremely high in patients with pulmonary edema. By using a two-dimensional presentation of Cpi vs. SVRi we found that these clinical syndromes can be accurately characterized hemodynamically. The paired measurements of each clinical group segregated into a specific region on the Cpi/SVRi diagnostic graph, that could be mathematically defined by a statistically significant line (Lambda=0.95). Therefore, measurement of SVRi and Cpi and their two-dimensional graphic representation enables accurate hemodynamic diagnosis and follow-up of individual patients with acute CHF. (C) 2003 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:443 / 451
页数:9
相关论文
共 23 条
[1]   CLINICAL AND HEMODYNAMIC PREDICTORS OF SURVIVAL IN PATIENTS AGED LESS-THAN-65 YEARS WITH SEVERE CONGESTIVE-HEART-FAILURE SECONDARY TO ISCHEMIC OR NONISCHEMIC DILATED CARDIOMYOPATHY [J].
ANGUITA, M ;
ARIZON, JM ;
BUENO, G ;
LATRE, JM ;
SANCHO, M ;
TORRES, F ;
GIMENEZ, D ;
CONCHA, M ;
VALLES, F .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (05) :413-417
[2]   Endothelial dysfunction in patients with heart failure: Relationship to disease severity [J].
Bank, AJ ;
Lee, PC ;
Kubo, SH .
JOURNAL OF CARDIAC FAILURE, 2000, 6 (01) :29-36
[3]   Non-invasive measurement of cardiac output during coronary artery bypass grafting [J].
Cohen, AJ ;
Arnaudov, D ;
Zabeeda, D ;
Schultheis, L ;
Lashinger, J ;
Schachner, A .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1998, 14 (01) :64-69
[4]   A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure [J].
Cohen-Solal, A ;
Tabet, JY ;
Logeart, D ;
Bourgoin, P ;
Tokmakova, M ;
Dahan, M .
EUROPEAN HEART JOURNAL, 2002, 23 (10) :806-814
[5]   Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema [J].
Cotter, G ;
Metzkor, E ;
Kaluski, E ;
Faigenberg, Z ;
Miller, R ;
Simovitz, A ;
Shaham, O ;
Marghitay, D ;
Koren, M ;
Blatt, A ;
Moshkovitz, Y ;
Zaidenstein, R ;
Golik, A .
LANCET, 1998, 351 (9100) :389-393
[6]   Acute heart failure: a novel approach to its pathogenesis and treatment [J].
Cotter, G ;
Moshkovitz, Y ;
Milovanov, O ;
Salah, A ;
Blatt, A ;
Krakover, R ;
Vered, Z ;
Kaluski, E .
EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :227-234
[7]   Pulmonary edema: new insight on pathogenesis and treatment [J].
Cotter, G ;
Kaluski, E ;
Moshkovitz, Y ;
Milovanov, O ;
Krakover, R ;
Vered, Z .
CURRENT OPINION IN CARDIOLOGY, 2001, 16 (03) :159-163
[8]   L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock [J].
Cotter, G ;
Kaluski, E ;
Blatt, A ;
Milovanov, O ;
Moshkovitz, Y ;
Zaidenstein, R ;
Salah, A ;
Alon, D ;
Michovitz, Y ;
Metzger, M ;
Vered, Z ;
Golik, A .
CIRCULATION, 2000, 101 (12) :1358-1361
[9]   The pathogenesis of acute pulmonary edema associated with hypertension. [J].
Gandhi, SK ;
Powers, JC ;
Nomeir, A ;
Fowle, K ;
Kitzman, DW ;
Rankin, KM ;
Little, WC .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :17-22
[10]   RITZ-5: Randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema - A prospective, multicenter, double-blind, placebo-controlled study [J].
Kaluski, E ;
Kobrin, I ;
Zimlichman, R ;
Marmor, A ;
Krakov, O ;
Milo, O ;
Frey, A ;
Kaplan, S ;
Krakover, R ;
Caspi, A ;
Vered, Z ;
Cotter, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (02) :204-210